| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 4M | $0.00 | $0 | Eight Roads Investments | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 620.5k | $0.00 | $0 | Eight Roads Investments | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 452.9k | $0.00 | $0 | Eight Roads Investments | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 179.2k | $0.00 | $0 | Eight Roads Investments | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 71.6k | $0.00 | $0 | ERVC Healthcare Advisors IV, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 10.2k | $0.00 | $0 | ERVC Healthcare Advisors IV, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 7.4k | $0.00 | $0 | ERVC Healthcare Advisors IV, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 494k | $0.00 | $0 | ERVC Healthcare V, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Ordinary Shares | 624.2k | $0.00 | $0 | ERVC Healthcare IV, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series A Convertible Preferred Shares | 4M | $0.00 | $0 | Eight Roads Investments | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series A+ Convertible Preferred Shares | 620.5k | $0.00 | $0 | Eight Roads Investments | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series B Convertible Preferred Shares | 452.9k | $0.00 | $0 | Eight Roads Investments | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series B-1 Convertible Preferred Shares | 179.2k | $0.00 | $0 | Eight Roads Investments | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series A Convertible Preferred Shares | 71.6k | $0.00 | $0 | ERVC Healthcare Advisors IV, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series A+ Convertible Preferred Shares | 10.2k | $0.00 | $0 | ERVC Healthcare Advisors IV, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series B Convertible Preferred Shares | 7.4k | $0.00 | $0 | ERVC Healthcare Advisors IV, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series B-1 Convertible Preferred Shares | 494k | $0.00 | $0 | ERVC Healthcare V, LP | 02/07/2023 |
| 02/07/2023 | Structure Therapeutics Inc. | | Conversion | Series A Convertible Preferred Shares | 624.2k | $0.00 | $0 | ERVC Healthcare IV, LP | 02/07/2023 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 218.7k | $0.00 | $0 | Eight Roads Investments | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 2.1M | $0.00 | $0 | Eight Roads Investments | 10/26/2021 |
| 04/23/2018 | Surface Oncology, Inc. | SURF | Conversion | Common Stock | 886.7k | $0.00 | $0 | | 04/23/2018 |
| 04/23/2018 | Surface Oncology, Inc. | SURF | Conversion | Series A Preferred Stock | 2M | $0.00 | $0 | | 04/23/2018 |
| 04/03/2018 | Cogent Biosciences, Inc. | UMRX | Conversion | Common Stock | 1.1M | $0.00 | $0 | | 04/03/2018 |
| 04/03/2018 | Cogent Biosciences, Inc. | UMRX | Conversion | Common Stock | 27.3k | $0.00 | $0 | | 04/03/2018 |
| 04/03/2018 | Cogent Biosciences, Inc. | UMRX | Conversion | Series A Preferred Stock | 1.7M | $0.00 | $0 | | 04/03/2018 |
| 04/03/2018 | Cogent Biosciences, Inc. | UMRX | Conversion | Series B Preferred Stock | 42.9k | $0.00 | $0 | | 04/03/2018 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 1.4M | $0.00 | $0 | | 12/12/2017 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 28.8k | $0.00 | $0 | | 12/12/2017 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 71.9k | $0.00 | $0 | | 12/12/2017 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 1.1M | $0.00 | $0 | Asia Ventures III L.P. | 12/12/2017 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 21.9k | $0.00 | $0 | Asia Ventures III L.P. | 12/12/2017 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 54.9k | $0.00 | $0 | Asia Ventures III L.P. | 12/12/2017 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 293.2k | $0.00 | $0 | Japan Ventures I L.P. | 12/12/2017 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 6k | $0.00 | $0 | Japan Ventures I L.P. | 12/12/2017 |
| 12/12/2017 | Denali Therapeutics Inc. | DNLI | Conversion | Common Stock | 15.1k | $0.00 | $0 | Japan Ventures I L.P. | 12/12/2017 |
|